Investor's Business Daily on MSN
GSK digs in on allergies with $2.2 billion Rapt Therapeutics buyout
GSK is buying Rapt Therapeutics for $2.2 billion, the companies said Tuesday. Rapt stock rocketed.
GSK has agreed to pay $58 per RAPT share, with an upfront payment of $1.9 billion, that will give it global rights to ...
That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...
A new underground industry has emerged where people are buying raw compounds for Ozempic, Botox, filler and skin-tightening treatments directly from Chinese suppliers — and injecting them at ...
Wegovy is now available as a daily oral pill with the same active ingredient as the injection. For some people, the pill may cause more intense side effects and slightly less weight loss than the ...
Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...
Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results